تجاوز إلى المحتوى الرئيسي
drug protocol number
D1690R0003
drug sponsor
AstraZeneca
drug study
Forxiga
drug trial site
King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah)
drug status
Ongoing
drug phase